<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Mol Cell Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">J Mol Cell Biol</journal-id>
<journal-id journal-id-type="publisher-id">jmcb</journal-id>
<journal-title-group>
<journal-title>Journal of Molecular Cell Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1674-2788</issn>
<issn pub-type="epub">1759-4685</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27330059</article-id>
<article-id pub-id-type="pmc">6080364</article-id>
<article-id pub-id-type="doi">10.1093/jmcb/mjw029</article-id>
<article-id pub-id-type="publisher-id">mjw029</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>BDNF rescues prefrontal dysfunction elicited by pyramidal neuron-specific DTNBP1 deletion <italic>in vivo</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Wen</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Daly</surname>
<given-names>Kathryn M.</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liang</surname>
<given-names>Bo</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Lifeng</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Xuan</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Yun</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
<xref ref-type="corresp" rid="mjw029cor1"></xref>
<!--<email>yunlijax@gmail.com</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Da-Ting</given-names>
</name>
<xref ref-type="aff" rid="mjw029af1">1</xref>
<xref ref-type="aff" rid="mjw029af2">2</xref>
<xref ref-type="aff" rid="mjw029af3">3</xref>
<xref ref-type="corresp" rid="mjw029cor1"></xref>
<!--<email>lind3@mail.nih.gov</email>-->
</contrib>
</contrib-group>
<aff id="mjw029af1">
<label>1</label>
<addr-line>Intramural Research Program</addr-line>, <addr-line>National Institute on Drug Abuse</addr-line>, <addr-line>National Institutes of Health</addr-line>, <addr-line>333 Cassell Drive</addr-line>, <addr-line>Baltimore, MD 21224</addr-line>, <country>USA</country></aff>
<aff id="mjw029af2">
<label>2</label>
<addr-line>The Jackson Laboratory</addr-line>, <addr-line>600 Main Street</addr-line>, <addr-line>Bar Harbor, ME 04609</addr-line>, <country>USA</country></aff>
<aff id="mjw029af3">
<label>3</label>
<addr-line>The Solomon H. Snyder Department of Neuroscience</addr-line>, <institution>Johns Hopkins University</institution><addr-line>School of Medicine</addr-line>, <addr-line>725 N. Wolfe Street</addr-line>, <addr-line>Baltimore, MD 21205</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp id="mjw029cor1"><label>*</label>Correspondence to: Yun Li, E-mail: <email>yunlijax@gmail.com</email>; Da-Ting Lin, E-mail: <email>lind3@mail.nih.gov</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>4</month>
<year>2017</year>
</pub-date>
<pub-date iso-8601-date="2016-08-17" pub-type="epub">
<day>17</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>9</volume>
<issue>2</issue>
<issue-title>Collection: New Insights into Neuroscience</issue-title>
<fpage>117</fpage>
<lpage>131</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>4</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>12</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Â© US Government (2016). Published by Oxford University Press on behalf of <italic>Journal of Molecular Cell Biology</italic>, IBCB, SIBS, CAS. All rights reserved.</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri xlink:href="mjw029.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>
<italic>Dystrobrevin-binding protein 1</italic> (<italic>Dtnbp1</italic>) is one of the earliest identified schizophrenia susceptibility genes. Reduced expression of DTNBP1 is commonly found in brain areas of schizophrenic patients. <italic>Dtnbp1</italic>-null mutant mice exhibit abnormalities in behaviors and impairments in neuronal activities. However, how diminished DTNBP1 expression contributes to clinical relevant features of schizophrenia remains to be illustrated. Here, using a conditional <italic>Dtnbp1</italic> knockout mouse line, we identified an <italic>in vivo</italic> schizophrenia-relevant function of DTNBP1 in pyramidal neurons of the medial prefrontal cortex (mPFC). We demonstrated that DTNBP1 elimination specifically in pyramidal neurons of the mPFC impaired mouse pre-pulse inhibition (PPI) behavior and reduced perisomatic GABAergic synapses. We further revealed that loss of DTNBP1 in pyramidal neurons diminished activity-dependent secretion of brain-derived neurotrophic factor (BDNF). Finally, we showed that chronic BDNF infusion in the mPFC fully rescued both GABAergic synaptic dysfunction and PPI behavioral deficit induced by DTNBP1 elimination from pyramidal neurons. Our findings highlight brain region- and cell type-specific functions of DTNBP1 in the pathogenesis of schizophrenia, and underscore BDNF restoration as a potential therapeutic strategy for schizophrenia.</p>
</abstract>
<kwd-group>
<kwd>schizophrenia</kwd>
<kwd>GABAergic</kwd>
<kwd>disinhibition</kwd>
<kwd>PFC</kwd>
<kwd>BDNF</kwd>
<kwd>
<italic>Dtnbp1</italic>
</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute on Drug Abuse</named-content>
<named-content content-type="funder-identifier">10.13039/100000026</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institutes of Health</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>